Sio Capital Management, LLC - Q1 2012 holdings

 Value Shares↓ Weighting
No holdings reported for quarter Q1 2012
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UNITED THERAPEUTICS ORD24Q4 20238.3%
VIKING THERAPEUTICS INC24Q3 20233.4%
CARDINAL HEALTH ORD20Q2 20227.2%
SANOFI SA19Q3 20229.8%
MEDTRONIC PLC19Q1 20245.2%
CATALYST BIOSCIENCES INC18Q3 202117.8%
PFENEX ORD18Q4 20195.9%
AEGLEA BIOTHERAPEUTICS INC18Q1 20231.1%
THE CIGNA GROUP17Q2 202411.0%
HCA HEALTHCARE INC17Q2 20225.5%

View Sio Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Sio Capital Management, LLC Q1 2012 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Aprea Therapeutics, Inc.February 14, 2024280,0007.5%
Gracell Biotechnologies Inc.February 14, 202425,007,9005.2%
Modular Medical, Inc.February 14, 20242,110,26010.0%
Modular Medical, Inc.February 13, 20231,091,47910.0%
Cellectar Biosciences, Inc.February 10, 2022? ?
CURIS INCFebruary 10, 20223,866,6454.2%
Salarius Pharmaceuticals, Inc.February 10, 20221,354,2913.0%
Larimar Therapeutics, Inc.February 16, 2021188,6611.2%
ACHIEVE LIFE SCIENCES, INC.February 14, 2020? ?
Bionano Genomics, IncFebruary 14, 20201,210,8214.6%

View Sio Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-26
13F-HR2024-08-14
13F-HR2024-05-15
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-12

View Sio Capital Management, LLC's complete filings history.

Compare quarters

Export Sio Capital Management, LLC's holdings